Jacob deGrom

Previewing Upcoming Opt-Out Decisions And Player Options

By Anthony Franco | August 30, 2022 at 11:59pm CDT

With the offseason approaching, so is the time for players and teams to decide upon any 2023 options in their contracts. MLBTR has taken a look through various option decisions in recent weeks: first with players whose deals contain vesting provisions, then a respective look at the team options in both the American and National Leagues.

Today, we’ll turn our attention to the players’ side. A number of players could hit free agency this winter either by triggering an opt-out clause in their current deal or bypassing a player option for the 2023 campaign. We’ll take a run through those decisions, many of which will have implications at the very top of the free agent market.

Note: All stats referenced are through play Sunday

Elite Potential Free Agents

Nolan Arenado, Cardinals 3B (can opt out of final five years and $144MM)

Arenado was already on a Hall of Fame trajectory before 2022, but he’s bolstering his case with the best season of his career. Through 500 plate appearances, he owns a .306/.370/.567 line with 27 home runs. He’s had seasons with that kind of slash line in years past, but they came with the caveat that he’d played half his games at Coors Field. That’s no longer a factor, and it’s easily his best offensive output once one adjusts for the ballpark. Arenado’s 162 wRC+ is the fourth-best mark among qualified hitters.

That kind of offensive production alone would get him in the MVP discussion, but Arenado’s obviously valuable for far more than his bat. One of the best defensive third basemen in MLB history, he’s continued to post elite marks with the glove even as he’s entered his 30s. Arenado is among the top handful of players in the game. While walking away from $144MM wouldn’t be an easy decision, it’d seem the prudent one from a strict financial perspective. Freddie Freeman received six years and $162MM from the Dodgers (albeit with deferrals that reduced the net present value closer to the $148MM range) headed into his age-32 season. Freeman was coming off a 135 wRC+ platform showing, and he plays a less valuable position. Arenado and his camp could make a strong argument the Freeman contract should represent his floor, and it’s not outlandish to seek a six-year deal at the $35MM annual range Anthony Rendon received from the Angels (which would bring the guarantee to $210MM).

On paper, Arenado’s opt-out decision looks like a slam dunk. There’s at least some amount of uncertainty, though, as he forewent an opt-out opportunity last offseason and told Derrick Goold of the Post-Dispatch it was “always the plan” to remain in St. Louis long term. Passing on free agency coming off a .255/.312/.494 showing in 2021 is a lot easier than doing so after a career-best year that should make him an MVP finalist. Maybe he’s comfortable enough with the Cardinals he’ll return, but he’d probably be leaving a lot of money on the table to do so. At the very least, he looks to have a case for a renegotiation of his contract with the Cards, which is slated to pay him just $15MM in the final season (2027).

Carlos Correa, Twins SS (can opt out of final two years and $70.2MM this offseason; deal also contains post-2023 opt-out if Correa opts in this winter)

Regarded by many (MLBTR included) as the top free agent in last winter’s class, Correa reportedly turned down at least one ten-year offer early in the offseason in search of a guarantee that rivaled the $341MM Francisco Lindor had received from the Mets last April. That proposal seemingly never came, and Correa reversed course in Spring Training. He signed a shocking three-year deal with the Twins that guaranteed him the largest annual salary ($35.1MM) for a free agent position player and afforded the opportunity to retest the market in either of the next two offseasons via opt-out.

Conventional wisdom was that Correa was sure to trigger his first opt-out and make another run at a long-term deal in a winter unaffected by a lockout. That still seems likely, although he hasn’t resoundingly made the case for teams to be more willing to approach the Lindor range that they had been. He’s having a similar offensive season as he did during his final year with the Astros. After posting a .279/.366/.485 showing his last year in Houston, Correa is hitting .276/.355/.439 over 440 plate appearances with Minnesota. His raw power production is down, but that’s not quite as alarming when considering the leaguewide slugging percentage has dropped from .411 to .395. Perhaps of greater concern is that the elite defensive marks that garnered Correa a Gold Glove last season are unanimously down, ranging anywhere from below-average (-2 Outs Above Average) to solid (+4 Defensive Runs Saved, +1 Ultimate Zone Rating).

There’s no question Correa’s an excellent player having a very good season. Yet he’s not likely to wind up a top five finisher in MVP balloting as he did in 2021. He’d top a $200MM guarantee on the open market, but he’s unlikely to reach the kind of money he anticipated last offseason. Could he return to Minnesota (where he’s by all accounts very happy) for one more year and look to trigger his post-2023 opt-out after hopefully putting up MVP-caliber numbers? That feels unlikely, but he’s already bet on himself once and would only be entering his age-29 season if he put off opting out for a year.

Xander Bogaerts, Red Sox SS (can opt out of final three years and $60MM)

Bogaerts has been the Red Sox’s everyday shortstop since 2014, but his time in Boston could be nearing its end. He and the club didn’t make progress in extension talks this spring, and he’s a lock to opt out and top $60MM on the open market barring a catastrophic injury. One of the game’s top offensive shortstops, Bogaerts is amidst another strong season. He carries a .303/.372/.448 line through 508 plate appearances. His slugging output is below where it was from 2018-21, but he consistently gets on base and has a strong pre-2022 track record from a power perspective.

One can quibble about certain aspects of Boagerts’ profile. In addition to this year’s slugging dip, he’s traditionally rated as a below-average defender. Even with generally solid defensive metrics this season, clubs will probably have some question whether he’ll eventually need to move to second or third base. Those are nitpicks for whether Bogaerts would be a worthwhile investment in the $180MM – $200MM range, though. A 30-year-old shortstop with an elite durability track record and a .299/.370/.478 line since the start of 2020, he’s certainly going to shatter $60MM even if the market takes a relatively pessimistic view of his long-term projection.

Jacob deGrom, Mets RHP (can opt of final year and $33.5MM this offseason)

There’s no suspense with this one, as deGrom has publicly maintained his plan to opt out for months. That’s in spite of elbow/shoulder injuries that kept him from throwing a major league pitch between July 2021 and this August. With only one guaranteed year remaining on his deal (plus a 2024 club option that’d go into effect if he doesn’t opt out this winter), that’s been a pretty easy call. To the extent there may have been any lingering doubts, deGrom has silenced them with his first five starts since returning from the injured list. He’s looked like his vintage self, averaging 99.3 MPH on his fastball while posting a laughable 46:2 strikeout-to-walk ratio through 29 1/3 innings. On an inning-for-inning basis, he’s the best starting pitcher on the planet.

deGrom’s free agent case will be fascinating. Even if he finishes the season healthy, he’ll have gone three consecutive years without topping 15 starts or 100 innings (although he’s obviously not at fault for the shortened 2020 schedule). What kind of volume a signing team can expect is an open question, particularly as he enters his age-35 season. Yet the upside of a healthy deGrom is through the roof. He’ll receive a multi-year deal that beats the $33.5MM remaining on his current contract. Can he top teammate Max Scherzer’s $43.333MM AAV over a three or even four-year term? Time will tell.

Justin Verlander, Astros RHP ($25MM option for 2023)

While we’re on the topic of upper-echelon starting pitchers who are basically certain to opt out, let’s turn to Verlander. The future Hall of Famer triggered a $25MM option for next season by throwing 130 innings, but that’s largely a moot point. Verlander told Ken Rosenthal of the Athletic last week he was likely to opt out if things went as planned down the stretch. It’d have been surprising if he were even considering exercising the option.

Verlander has returned from 2020 Tommy John surgery to lead the major leagues with a 1.84 ERA. He’s striking out 26.5% of opponents and has a strong argument for a third career Cy Young award. He’s also a proven playoff performer and a prototypical ace who eats about as many innings as anyone else in the game. Even heading into his age-40 season, Verlander can try to beat the Scherzer AAV on a multi-year contract.

Verlander did injure his calf in his most recent start, resulting in a placement on the injured list just this afternoon. The Astros announced that an MRI of his calf revealed “fascial disruption, but no muscle fiber disruption” — an extremely specific diagnosis but one that both Verlander and GM James Click touted as good news. Click expressed hope the injury will be short-term, and Verlander suggested that had he sustained damage to the muscle fibers themselves, he’d likely have missed the remainder of the regular season and perhaps part of the postseason.

The manner to which Verlander rebounds will obviously be key in his opt-out scenario, but if he misses only a couple weeks’ time and returns strong for his final regular-season and postseason starts, this opt-out is an easy call.

Carlos Rodón, Giants LHP ($22.5MM option for 2023)

We’ll wrap up the trifecta with Rodón, who’s also going to have an easy decision, barring injury. While there was some trepidation about Rodón’s breakout 2021 season — both due to his inconsistent track record before last season and some shoulder soreness and a velocity drop last August — he’s doubled down and looks to have cemented himself among the game’s top ten starters. Rodón has avoided the injured list thus far, and he’s striking out 32.1% of opponents while posting a 2.81 ERA through 25 starts. By topping 110 innings, he earned the right to opt out after this season.

Heading into his age-30 campaign, he should land the nine-figure deal that eluded him last offseason. Between his youth and last two years of production, Rodón has an argument for the largest guarantee of any free agent starter. He won’t get paid at the deGrom or Verlander level on an annual basis, but he could push for six years and look to top $150MM.

Quality Regulars Likely To Opt Out

Anthony Rizzo, Yankees 1B ($16MM option for 2023)

Rizzo’s market last offseason seemed a bit underwhelming. The veteran first baseman was coming off two fine but unspectacular seasons, and it looked as if his best days might be behind him with his mid-30s approaching. Rizzo still made plenty of contact and hit the ball hard, but he’d gotten quite pull-oriented and had rough ball-in-play results against an increasing number of defensive shifts. He signed a two-year deal with the Yankees that paid him matching $16MM salaries and allowed him to opt out after this season.

That now looks like an easy call, as Rizzo has bounced back with a year more reminiscent of his peak days with the Cubs. He carries a .223/.337/.480 line and is going to top 30 homers for the first time since 2017. He’s still getting dismal results on balls in play and doesn’t have a particularly impressive batting average, but even that looks as if might turn around next year. It’s widely expected MLB will institute limits on shifting next spring. Few players would stand to benefit more than Rizzo, who’s facing a shift on a whopping 83.5% of his plate appearances according to Statcast. His age and lack of defensive versatility will limit the length of any deal, but he’ll probably beat the $16MM salary over at least a two-year term, even if the Yankees tag him with a qualifying offer.

Jurickson Profar, Padres LF ($8.5MM option, $1MM buyout)

The Padres’ signing Profar to a three-year, $21MM deal that allowed him multiple opt-out chances was one of the more eyebrow-raising moves of the 2020-21 offseason. The switch-hitter was coming off a solid 2020 campaign, but that shortened schedule was the first in which he’d posted above-average production. It looked like a misstep when he struggled last year and unsurprisingly forewent his first opt-out clause, but Profar has rewarded the organization’s faith with a career-best showing in 2022.

Through 530 plate appearances, he’s hitting .241/.339/.387 with 12 homers. He’s walking at a robust 12.3% clip while only going down on strikes 15.1% of the time. He looks like a solid regular, and headed into his age-30 season, Profar’s a candidate for another multi-year deal this time around. After major throwing issues as an infielder early in his career, he’s played exclusively left field this year. Profar isn’t a prototypical corner outfield masher, but his plate discipline and bat-to-ball skills should allow him to top the guaranteed money remaining on his current deal.

Starting Pitchers With High Buyouts

Taijuan Walker, Mets RHP ($6MM option, $3MM buyout)

Walker signed a $20MM guarantee with the Mets over the 2020-21 offseason. The deal was front-loaded but came with a $6MM player option or a $3MM buyout for 2023. Adding a player option allowed the Mets to soften the contract’s luxury tax hit. Because player options are treated as guaranteed money, it technically qualified as a three-year, $20MM deal with a $6.67MM average annual value for CBT purposes. Yet the $3MM gap between the option value and the buyout meant Walker was a virtual lock to opt out, barring injury that made him unable to pitch next season. The Associated Press reports the option has various escalators that could push its value as high as $8.5MM if Walker throws 175 innings this year, but even that figure is modest enough he’s going to decline.

Walker should opt out in search of a multi-year deal, as he’s been a valuable mid-rotation arm for New York. Over 117 1/3 frames, he owns a 3.38 ERA despite a modest 18.3% strikeout rate. His blend of plus control and solid ground-ball rates makes him a candidate for a three-year pact as he heads into his age-30 season. The Mets will have an interesting decision on whether to tag him with a qualifying offer.

Jake Odorizzi, Braves RHP ($12.5MM option, $6.25MM buyout)

Like Walker, Odorizzi signed late in the 2020-21 offseason on a deal that locked in the first two seasons and gave the player a third-year option. Odorizzi’s contract with the Astros was similarly structured to facilitate a third-year buyout while diminishing the AAV for luxury tax purposes, although he’s deciding on a bit more money. The option was initially valued at $6.5MM with a $3.25MM buyout, but the Associated Press provided a breakdown of various escalators. The option value would jump by $2MM apiece if Odorizzi reached 20, 25 and 30 appearances between 2021-22 in which he either started the game or worked four-plus innings of relief. The buyout value would spike by $1MM apiece for hitting each of those thresholds.

Odorizzi has already made 41 such appearances over the past two years, so he’s long since maxed out both thresholds. He’ll therefore be deciding between a $12.5MM option to return to the Braves or taking a $6.25MM buyout and heading to free agency. With only a $6.25MM difference between the option value and the buyout, Odorizzi looks like a borderline opt-out case. He owns a 3.90 ERA across 85 1/3 innings this season, although his 18.3% strikeout rate is a few points below league average. He’ll be 33 by next Opening Day, and he didn’t find as robust interest as most expected he would during his last trip through free agency. He’s a quality strike-thrower and a perfectly fine back-of-the-rotation starter, but it’s now been three years since he’s missed bats at an above-average rate, and he was traded this summer in a one-for-one swap for an underperforming reliever (Will Smith).

Easy Calls To Return

Chris Sale, Red Sox LHP (can opt out of final two years and $55MM)

Sale has the right to pass on the final two years of his extension with the Red Sox this winter, but he certainly won’t do so. He’s made just 11 starts over the past three seasons due to various injuries, including a 2020 Tommy John surgery and a trio of fractures (rib, finger and wrist) this year. Sale has still flashed mid-rotation or better upside in the limited time he’s been on the field, but there’s too much uncertainty with his health to land anywhere near $55MM were he to test the market.

Eric Hosmer, Red Sox 1B (can opt out of final three years and $39MM)

Hosmer’s opt-in decision is a no-brainer. Since signing a $144MM contract with the Padres heading into 2018, he’s posted a league average .264/.325/.409 slash line. Paired with his lack of defensive versatility and mixed reviews on his glovework (public metrics have never been as fond of Hosmer as his four Gold Gloves would suggest), he’d probably be limited to one-year offers were he a free agent. The Padres will remain on the hook for virtually all of the money, as they agreed to pay down Hosmer’s deal to the league minimum salary to facilitate his trade to the Red Sox.

Jorge Soler, Marlins LF (can opt out of final two years and $24MM; deal also contains post-2023 opt-out if Soler opts in this year)

Soler parlayed a big second half and huge batted ball metrics into a three-year deal with Miami last offseason. His massive raw power hasn’t translated into especially strong results since he’s become a Marlin, however. He’s been a below-average hitter, and it’s now been three years since he was a middle-of-the-order caliber player over a full season. Paired with a limited defensive profile that keeps him in the corner outfield or at designated hitter, he’s been right around replacement level this season. He’s not opting out this year, but a big showing in 2023 could allow him to reconsider the possibility next winter.

AJ Pollock, White Sox LF ($11MM option, $5MM buyout)

The White Sox acquired Pollock just before the start of the season, sending Craig Kimbrel to the Dodgers in a surprising one-for-one swap. The hope was that they’d addressed a notable hole in the corner outfield, but Pollock’s production has cratered in Chicago. Just a season removed from a .297/.355/.536 showing in L.A., he’s stumbled to a .237/.284/.363 line through 401 plate appearances with the ChiSox. Even with a fairly modest $6MM gap between the option’s present value and the buyout, Pollock is likely to bypass a trip to free agency after a replacement-level platform season.

The present $11MM option value isn’t fixed, as Pollock’s contract contains escalators that could boost it a bit further. Originally set at $10MM, he’d lock in an extra $1MM for hitting each of 400, 450, 500, 550 and 600 plate appearances this season. He’s already surpassed 400 trips, and the 450 mark is well within range with 34 games remaining. Consistent playing time down the stretch would allow him to reach 500 plate appearances as well, although it’s hard to envision him getting to 550. The most likely outcome is that the option price ends up at $12MM, but anywhere between $11-13MM is viable.

Jonathan Schoop, Tigers 2B ($7.5MM option)

Schoop signed a two-year, $15MM extension amidst a productive 2021 season in Detroit. While a defensible enough decision for the Tigers at the time, that hasn’t panned out. The veteran second baseman has a .235 on-base percentage that’s easily the worst in the majors among players with 400+ plate appearances. He’s posted otherworldly defensive marks this season and could well collect a Gold Glove, but the complete lack of production at the dish should make him a lock to exercise his option.

Charlie Blackmon, Rockies DH/RF ($12MM option)

Blackmon exercised a 2022 option last season, and he went on the record at the time as saying he’d trigger the 2023 provision as well. There’s no intrigue as to his decision — he’ll be back in Colorado next year — the only question is how much he’ll make. The ’23 option came with a $10MM base value, but ESPN reported it’d escalate by $500K apiece if Blackmon reached 400, 425, 450, 475, 500, and 525 plate appearances in 2022. It’d jump another $1MM apiece at 550 and 575 trips.

The veteran outfielder enters play Tuesday with 490 plate appearances, so he’s already pushed the value to $12MM. Barring injury, he’s a lock to hit at least the 525 PA mark, and he’s quite likely to get all the way to 575. Colorado has 33 games remaining, and Blackmon is only 85 plate appearances (2.76 per game) from maxing out the plate appearance threshold at $15MM. The deal also contained escalators based on MVP finishes which Blackmon will not hit.

Relievers

Nick Martinez, Padres RHP (can opt out of final three years and $19.5MM this offseason, $1.5MM buyout; deal also contains opt-out chances after 2023 and 2024 if Martinez opts in)

Martinez signed a four-year, $25.5MM guarantee with San Diego this past winter. That deal contained opt-out chances after each of the first three seasons for the former NPB hurler, but it seems unlikely Martinez will take his first opportunity to return to the open market. He has a strong 3.02 ERA over 92 1/3 innings during his return season in the big leagues, but he’s worked as a swingman for a San Diego team that has quite a bit of rotation depth. Martinez has excelled as a reliever, pitching to a 1.35 ERA while holding opponents to a .208/.258/.295 line in 40 innings. That’s come with a modest 21.5% strikeout rate, though, and he doesn’t brandish the power arsenal teams tend to prioritize late in games.

Entering his age-32 season, Martinez probably wouldn’t find a better deal that the opt-out laden three years and $18MM (after factoring in the buyout price) he’d be bypassing to return to the open market. The Friars have to be happy with their investment considering his excellence out of the bullpen, but the surprisingly strong deal they gave him in the first place makes it hard to see him doing much better elsewhere even on the heels of a quality first season.

Andrew Chafin, Tigers LHP ($6.5MM option)

Detroit signed the ever-reliable Chafin late last offseason, and they’ve been rewarded with another excellent year. Through 43 1/3 innings, he’s posted a 2.91 ERA while striking out more than 30% of opponents with an excellent 52.3% ground-ball rate. The market probably undervalued Chafin last winter; it’d be hard to do so again after another very good season. In a vacuum, declining the option and topping $6.5MM in free agency seems likely.

That said, the Tigers decision to not trade Chafin at this summer’s deadline was tied to a belief he could stick around. Evan Petzold of the Detroit Free-Press reported shortly before the deadline that Detroit’s proximity to Chafin’s Ohio home could lead him to return in 2023 if he weren’t moved before August 2. That led to a disconnect in his trade value, with the Tigers confident they still possessed a year and a half of his services while other clubs viewed him as an impending free agent. From a strict financial perspective, opting out is the prudent call. Yet the family considerations Petzold noted would make the decision more complicated if Chafin’s priority isn’t simply to maximize his earnings.

Robert Suárez, Padres RHP ($5MM option, $1MM buyout)

San Diego added Suárez, who’d never previously pitched in the majors, on the heels of an excellent career closing in Japan. He had a nightmare outing on Opening Day where he dished out free passes to all three batters he faced, but he’s been quite effective since that point. Excluding his first appearance, Suárez owns a 2.36 ERA with a strong 29% strikeout rate in 34 1/3 innings. He’s still had spotty control, but he’s averaging north of 97 MPH on his fastball. He’d only need to beat $4MM on the open market, and something around that rate over a multi-year term feels attainable heading into his age-32 season. A rough final couple months could change the calculus, but Suárez seems likely to retest free agency at the moment.

Forecasting The 2022-23 Qualifying Offers: Pitchers

By Mark Polishuk | August 14, 2022 at 10:15am CDT

Yesterday, we took a look at the pending free agent position players who could be candidates to receive a qualifying offer this winter. Now, let’s turn our attention to what free agent pitchers might be in line for a QO, with the caveat that players can only receive one qualifying offer in their careers, and a player must spend the entire 2022 season with his team to be eligible.

Easy Calls: Chris Bassitt (Mets), Jacob deGrom (Mets), Edwin Diaz (Mets), Nathan Eovaldi (Red Sox), Carlos Rodon (Giants)

DeGrom has already said that he is opting out of the final guaranteed season of his contract, leaving $30.5MM on the table in 2023 to seek out a longer-term pact. Rodon is also sure to opt out of the final year (and $22.5MM) of his two-year contact with San Francisco, as Rodon earned his opt-out by triggering a vesting option at the 110-innings threshold.

Even with Eovaldi’s injury history, retaining him for one year at roughly $19MM seems like a pretty good outcome for the Red Sox, particularly given all the other question marks in Boston’s rotation. So there’s little risk for the Sox in issuing Eovaldi a QO, though it would seem like Eovaldi will probably reject it.

Face-of-the-Franchise Veterans: Clayton Kershaw (Dodgers), Adam Wainwright (Cardinals)

With Kershaw considering retirement last winter, the Dodgers opted against issuing him a qualifying offer as a free agent, as a nod towards giving the longtime ace all the time he needed to make a decision on his future. It stands to reason that the Dodgers will take the same path this winter, unless Kershaw gives them advance notice of his plans for 2023….though in that scenario, the two sides might just work out an extension before free agency even officially opens.

The same could be true of Wainwright, who has signed one-year contracts to rejoin the Cardinals in each of the last four offseasons. In three of those cases, Wainwright inked his new deal either just after the start of the free agent period or before it altogether, so it’s safe to assume the two sides will work out a new pact without the QO coming into play. Of course, this assumes that Wainwright will come back for an 18th Major League season, but even as his 41st birthday approaches, the right-hander is still going strong.

Easy Contract-Option Calls: Carlos Carrasco (Mets), Sonny Gray (Twins), Aaron Nola (Phillies)

These starters could be free agents if their club options are declined, and thus are technically qualifying-offer candidates. However, the trio are all virtual locks to have their options exercised, and their respective options are all worth less than the projected cost of the qualifying offer.

Borderline Cases: Tyler Anderson (Dodgers), Mike Clevinger (Padres), Zach Eflin (Phillies), Sean Manaea (Padres), Martin Perez (Rangers), Jameson Taillon (Yankees), Taijuan Walker (Mets)

Walker is yet another Mets entry on this list, as he is very likely to decline his $6MM player option for 2023 and instead take a $3MM buyout into free agency. Advanced metrics paint a less-flattering picture of Walker’s performance than his bottom-line numbers, and he has battled both injury and consistency problems over his career, though Walker has been relatively healthy in his two seasons in New York. It would seem likely that the Mets will issue Walker a QO, and 2022 has been enough of a platform year for the righty that he will probably turn the qualifying offer down.

The Padres are another team with multiple QO candidates, as while Joe Musgrove was kept off the open market with a $100MM extension, Manaea and Clevinger remain. Due in part to two particularly disastrous outings against the Dodgers, Manaea’s ERA is an ungainly 4.76 over 119 innings. Clevinger has a solid 3.47 ERA in his return from Tommy John surgery, but that is only over 70 innings, due to both his TJ rehab as well as a triceps strain and a week on the COVID-related IL.

Right now, Manaea and Clevinger could possibly be candidates to accept a qualifying offer, if they don’t feel they have enough of a platform to maximize their free agent market. Solid performances over the final month and a half of the season would make it an easier decision for either pitcher to reject a QO, and easier for the Padres to decide whether or not to issue the offers. San Diego could be facing a third consecutive year of luxury-tax overage in 2023, especially if Manaea and/or Clevinger are on the books for a $19MM-ish salary.

Eflin is another player who needs to post some solid numbers down the stretch, but first and foremost, the Philadelphia right-hander just needs to get healthy. Eflin has been on the IL since late June due to a kneecap bruise, and his continued knee soreness is a red flag for a pitcher who has undergone multiple knee surgeries in the past. When healthy, Eflin has been a quietly solid pitcher for the Phillies over the last five seasons, yet his lingering knee problems are certainly a concern. There is the interesting wrinkle of a $15MM mutual option between Eflin and the Phils for 2023, and while mutual options are rarely exercised by both parties, this could be a rare situation where it would make sense for both the player and the team. Paying $15MM for Eflin would also represent some risk for the Phillies, but it would be less than the value of a qualifying offer.

After a great start to the season, Taillon’s numbers have come back to earth a bit, with a 3.95 ERA over 120 2/3 innings. A below-average strikeout pitcher, Taillon has relied on excellent control and spin rates on his fastball and curve to limit damage, and he also doesn’t allow too much hard contact. Perhaps most importantly given Taillon’s injury history, he has been healthy in 2022, which should make offseason suitors more open to giving him a longer-term contract. For now, it seems probable that the Yankees would issue Taillon a QO rather than let him potentially walk away for nothing in free agency.

The idea of Anderson or Perez as QO candidates would’ve seemed quite farfetched heading into the season, yet the two veteran left-handers are each enjoying career years that resulted in All-Star appearances. Their underwhelming career histories could prevent the Dodgers and Rangers from issuing qualifying offers, since either pitcher would likely take the big payday, and $19MM is a lot to invest in basically one season of evidence (even for a Dodgers team that is comfortable blowing past luxury tax thresholds).

However, it would certainly make sense for either club to pursue re-signings, even if a qualifying offer isn’t involved. The Rangers have already been vocal about their desire to retain Perez, so it is quite possible he signs an extension before even hitting the open market.

2022-23 MLB Free Agent Power Rankings: August Edition

By Steve Adams | August 9, 2022 at 11:57pm CDT

A lot has changed since the last edition of MLBTR’s Free Agent Power Rankings. Joe Musgrove, formerly the No. 5 entrant on the list, has since signed a five-year extension with his hometown Padres, keeping him from reaching the market. Willson Contreras, the No. 9 entrant on that edition of the list, was somewhat stunningly not traded at the deadline, meaning he’ll be subject to draft-pick compensation. Jacob deGrom had yet to pitch at that point in the season but has now made a dominant pair of outings in his 2022 debut. More broadly, several players on the list or on the “honorable mention” portion of the list have altered their stock with strong play or faded.

Here’s a look at where things stand, with a reminder that this list is based on what the MLBTR team believes to be each player’s earning power in free agency — not necessarily a ranking of the “best” free agents or who’ll hold up the best over the life of a major free-agent contract.

1. Aaron Judge, OF, Yankees (Last ranked: 1): While plenty has changed since the May 25 version of these rankings, it’s business as usual for Judge, who boldly turned down a seven-year, $213.5MM extension offer back in Spring Training and now looks prescient for doing so. Judge was hitting .314/.386/.692 at the time of our last rankings and has followed that with a remarkably consistent .292/.390/.654 line in 64 games since. Judge is on pace to top Roger Maris’ 61 home runs from the 1961 season, leading the Majors not only in long balls (44) but also runs scored (93), RBIs (98), slugging percentage (.677), OPS (1.068) and wRC+ (196). He’s leading the AL with 122 hits and has even stolen a career-high 11 bases (without being caught).

Judge has been the best hitter on the planet since Opening Day, and as things currently stand, the only person who could conceivably stand in his way of winning his first AL MVP trophy would be Angels sensation Shohei Ohtani. However, great as Ohtani has been again in 2022, his offense isn’t quite what it was last year (and isn’t anywhere close to Judge’s league-leading dominance). From a pure WAR perspective, Judge has been so good this year that his value with the bat has eclipsed Ohtani’s combined value at the plate and on the mound.

Regardless, Judge is now poised to reach free agency on the heels of the finest season of his already brilliant big league career. He’ll play the 2023 season at age 31, which is about the only strike against him in free agency. Judge will receive and reject a qualifying offer from the Yankees, and even though he’d be 38 by the end of an eight-year deal, that seems plenty plausible. He could very well command the largest annual salary any position player has ever received, too, and a $300MM overall contract doesn’t seem out of the question. This is what it looks like to bet on yourself and win — in resounding, overwhelming fashion, no less.

2. Trea Turner, SS, Dodgers (LR: 3): There’s not much on the baseball field that Turner doesn’t do well. The 29-year-old is the sport’s fastest player, by measure of Statcast’s Average Sprint Speed, and he’s hitting .305/.345/.499 as of this writing. The 28 home runs he popped in 2021 might very well go down as a career-high, but Turner should finish this year around 25 dingers and has twice in the past hit 19 long balls (including in a 2019 season where he played in just 122 games).

That injury shortened ’19 campaign was the only one in the past half decade in which Turner spent significant time on the shelf. Over the past five years, he’s a .303/.358/.493 hitter who’s made a pair of All-Star teams, won a batting title and taken home a World Series ring.

By the end of a long-term deal, Turner will probably move off shortstop, but he’s a solid option there for now who’d be plenty capable of sliding over to second base at some point. Over the past three seasons, he’s been 43% better than league-average with the bat, by measure of wRC+, and this will be his fourth season of at least four wins above replacement in the past five years — with the 60-game 2020 season, when he boasted 2.8 fWAR and bWAR alike, being the lone exception.

If Turner had been born a day later, next year would technically be considered his age-29 season, but he’ll be 30 on June 30, and the July 1 cutoff is (for whatever reason) generally seen as the arbitrary turning point for a player’s age in a given year. A seven-year deal for Turner would run through age-37, and an eight-year deal through age-38. He’ll have to contend with a qualifying offer and another deep class of shortstops, but Turner is one of baseball’s most well-rounded players and figures to be compensated in line with the game’s 10 to 20 best position players.

3. Nolan Arenado, 3B, Cardinals (LR: 6): It’s difficult to directly compare Arenado’s 2022 season and the 2019 season that propelled Anthony Rendon to a seven-year, $245MM contract, given that Rendon’s Herculean ’19 effort came during the juiced-ball season. Offense is down league-wide now, yet Arenado stacks up favorably in terms of batting average, on-base percentage and slugging percentage. Metrics like wRC+ and OPS+, which weight for both home park and league environment, feel that Arenado’s 2022 production at the plate has actually been slightly better.

Defensively, Arenado is nearly peerless at his position. Since making his MLB debut in 2013, Arenado ranks second among all players, regardless of position, with 151 Defensive Runs Saved, trailing only Andrelton Simmons. He’s third to Francisco Lindor and Nick Ahmed in Statcast’s Outs Above Average, which tracks defensive data dating back to 2016. Arenado’s numbers aren’t inflated by early-career marks, either. He remains elite this season, ranking third in all of MLB in DRS and second in OAA. Defensive metrics and the eye test agree, as Arenado has been a human highlight reel at the hot corner for his decade-long career.

The age gap between 2022 Arenado (31) and 2019 Rendon (29) can’t be ignored. However, that should be more reflected in the length of a theoretical Arenado contract than in the annual value. It’s also, of course, worth noting that Arenado is technically under contract through 2027. He’s guaranteed $144MM in that time but has the right to opt out of the contract after the current season. Arenado forwent an opt-out clause after the 2021 season, but his 2022 campaign is the best of his career.

Even if he’s capped at a five-year deal in free agency, he should be able to trounce the current $28.8MM annual value remaining on his deal by as much as $5-7MM — and a six-year deal doesn’t seem impossible to imagine coming off such a brilliant effort. (Freddie Freeman scored a six-year deal beginning with his age-32 season, so there’s recent precedent.) Perhaps Arenado and the Cardinals will work out a compromise, and it’s always possible he decides he’s happy in St. Louis and just passes on the opt-out entirely. If he does want to test the market again, however, there could be another $20-60MM in earning power for him on top of his current deal.

4. Carlos Correa, SS, Twins (LR: 2): The 2022 season might not have gone quite as well as either Correa or the Twins hoped, but he’s still enjoying a sound all-around year, hitting .265/.343/.433 (22% better than league average, by measure of wRC+). He got out to a slow start in April and has slumped following the All-Star break, but for a three-month stretch from late April to late July, Correa hit .308/.375/.509. Provided the current slump doesn’t last too long, Correa stands a decent chance to be around 30% better than average at the plate for the second straight season and third time in four years.

Last year’s all-world defensive ratings have taken a dip thus far in 2022 — surprising for a player who has generally been a consistent source of elite glovework. He’s made five throwing errors this season, tied for his most since 2016, but Correa has been plenty sure-handed, booting just two balls hit to him. He’s spent the year throwing to Miguel Sano and a pair of makeshift first baseman who’ve converted from other positions (Luis Arraez, Jose Miranda), so perhaps some of the throwing miscues can be forgiven by a team with a better defensive outlook at first base.

If those first couple paragraphs feel like they’re filled with caveats — well, they are. The simple fact is that Correa hasn’t had as strong a season as he did in 2021 and probably shouldn’t be expected to command the type of contract many (MLBTR included) thought to be possible last offseason. That said, Correa still hasn’t even turned 28 — the age at which he’ll play nearly all of the 2023 season. His youth alone gives him the chance to command the longest contract of any free agent this winter; even a 10-year deal would run through age-37.

That type of contract may not be on the table without a huge finish, but Correa is still a plus defender and well above-average hitter with age on his side. It’s perhaps narrowly more plausible that he could opt into a second year with the Twins, take another $35.1MM salary and hope to hit free agency on the heels of a stronger platform in 2023, but his current earning power is still among the best in this year’s free-agent class.

5. Xander Bogaerts, SS, Red Sox (LR: 4): When the last version of our list was published, Bogaerts had homered just four times in 174 plate appearances while posting a below-average .135 ISO (slugging minus batting average). It was easy enough to overlook as little more than small-sample noise at the time, but Bogaerts has hit just five home runs in 267 plate appearances since that time and now has nine long balls and a tepid .141 ISO in 441 trips to the plate. That’s the worst power output we’ve seen from Bogaerts since 2017 by an overwhelming margin. From 2018-21, he belted 90 homers in 2106 plate appearances while turning in a stout .224 ISO.

Bogaerts is still hitting .311/.383/.452 on the season, but he’s also sporting a career-high .382 average on balls in play that he’s not going to sustain — particularly not when his average exit velocity, barrel rate and hard-hit rate are at their lowest or near-lowest levels since 2017.

There’s still no doubt that Bogaerts will opt out of the remaining three years and $60MM on his contract, but he’d be higher on this list if not for his power stroke going MIA. Couple that with ongoing questions about his defense — some teams are surely going to see Bogaerts as a player who needs to move off shortstop, perhaps as soon as 2023 — and the current free-agent outlook is a bit murkier than expected.

Nevertheless, Bogaerts has a long track record of excellent offense and well above-average power output. With a strong finish to the season, particularly in the power department, he should have no problem commanding a notable nine-figure deal — and something in excess of $200MM can’t be ruled out.

6. Jacob deGrom, RHP, Mets (LR: 7): The No. 6 ranking here for deGrom factors in something of a best-case scenario, but this list is based on earning power, after all. If deGrom gets hurt again or struggles down the stretch, it’s possible he’ll drop off the list entirely. The latter of those two scenarios seems unlikely, though, as deGrom hasn’t “struggled” since 2017. He’s been dominant through his first two starts of the 2022 season, averaging 99.2 mph with his fastball and holding opponents to three runs on four hits and a walk with 18 punchouts through 10 2/3 innings.

Dating back to 2018, deGrom has a comical 1.95 ERA in 591 2/3 innings with a 34.9% strikeout rate against a 5.3% walk rate. When healthy, deGrom is simply unmatched in terms of starting pitching dominance over that period. He ranks second among all Major League pitchers with 24 wins above replacement dating back to 2018, per FanGraphs, despite the fact that he’s made only 93 starts in that time. Max Scherzer tops the list but has started 24 more games and logged 143 2/3 more innings — about an extra 75% of a season’s worth of work.

If deGrom finishes the season with no red flags, the bidding should be furious. He’ll turn 35 next June, making him nearly three full years younger than Scherzer was when he secured his record-setting three-year, $130MM deal from the Mets. DeGrom could justifiably look to top that AAV on a multi-year deal, and he’s too good for the bidding to stop at two years. The biggest question surrounding deGrom is just how many years someone will be willing to guarantee. A three-year pact in excess of Scherzer’s seems doable, and a fourth year ought to be on the table as well.

7. Dansby Swanson, SS, Braves (LR: Not Ranked): Long a plus defender at shortstop, Swanson is having another strong year with the glove and a career year with the bat. He’s followed up a career-high 27 home runs in 2021 with a .292/.348/.461 showing through 463 trips to the plate. He’s been the beneficiary of a .375 average on balls in play that he surely won’t sustain over a larger sample, but Swanson is also making hard contact at a career-best 44.7% clip and elevating the ball more than he has in years past.

A greater walk rate than his current 7.3% clip or lower strikeout rate than his 26.3% mark would raise Swanson’s floor, but his glove alone will make him an above-average regular and he’s well on his way to his second straight 25-homer season. Add in that Swanson will play all of next season at 29 years old, and a nine-figure deal seems likely. Both Trevor Story and Javier Baez landed six-year, $140MM pacts last winter at the same age. Swanson will have to contend with a qualifying offer and with some more decorated shortstop options ahead of him on the market, but he’ll be in high demand all the same.

8. Carlos Rodon, LHP, Giants (LR: 8): Rodon was the best pitcher in baseball through late July in 2021, but he was capped to five innings per appearance (at most) down the stretch as he battled shoulder fatigue and diminished velocity. For a pitcher with Rodon’s injury history, that limited interest in him to the point that he took a two-year, $44MM deal with a chance to opt out following the 2022 season — provided he reached 110 frames.

Rodon has not only reached 110 innings — he’s shot past it with career-best velocity (95.8 mph average fastball) and another sub-3.00 ERA (2.95 through 128 1/3 frames thus far). Rodon is averaging just shy of six innings per outing and boasts a 31.2% strikeout rate against a 7.6% walk rate. He’s reached double-digit strikeouts in six of his 22 starts and held opponents to three or fewer runs in 18 of 22 tries.

Rodon’s fastball in his past eight starts is down about one mile per hour over his average from his first 14 starts, but it’s still been a healthy 95.1 mph in that stretch. That said, he threw a complete game on July 9, worked seven shutout innings on July 31, and averaged a resurgent 96 mph with his heater in his most recent outing. At least so far, Rodon doesn’t appear to be fading at all. If he can avoid the type of late swoon he experienced in 2021, he ought to find four- and five-year offers at superior annual values to this contract’s $22MM AAV. He’ll receive a qualifying offer and surely reject it, which isn’t ideal, but he has the best combination of age (30 all of next season) and 2022 performance of any starter on this year’s market.

9. Justin Verlander, RHP, Astros (LR: Not Ranked): Simply returning to make a full season’s worth of starts would’ve been a feat for a 39-year-old who had pitched just six innings since the end of the 2019 season due to Tommy John surgery. Verlander, of course, is no ordinary 39-year-old, and he’s not only returned but positioned himself as a front-runner for the AL Cy Young Award.

It’s a jaw-dropping feat, even for one of this generation’s best. Verlander has a 1.73 ERA with a 25.5% strikeout rate against a minuscule 4.6% walk rate. He’s averaging nearly 6 2/3 innings per start, sitting 95.1 mph with his heater — his second-best mark since way back in 2011 — and has thrown a quality start in 16 of his 20 appearances this year. Verlander hasn’t yielded more than one earned run in a start since June 18 and has held opponents to one or zero earned runs in a stunning 15 of 20 starts.

He’ll turn 40 in February, but Verlander has a legitimate case to break Max Scherzer’s $43.33MM AAV, particularly if he’s looking at a two-year deal. He’s said he wants to pitch into his mid-40s and looks as good as ever, though, so we shouldn’t discount the possibility that a team shrugs and goes to three guaranteed years for this generation’s most prolific workhorse. Verlander unlocked a $25MM player option when he reached 130 innings pitched, but he should be able to crush that in free agency even if he prefers to work out an extension with Houston.

10. Edwin Diaz, RHP, Mets (LR: Not Ranked): It’s been six years since Mark Melancon (four years, $62MM), Kenley Jansen (five years, $80MM) and Aroldis Chapman (five years, $85MM) each set new records for relief contracts in the same offseason. Diaz, the most dominant reliever in baseball this season, will have a chance to topple that Chapman record when he heads into free agency in advance of his age-29 season.

After a nightmarish first season in Queens, Diaz has righted the ship and become a spectacle in the best kind of way. He’s averaging 99.1 mph on his heater this season, has punched out 52.9% of his opponents and has an entrance more befitting of a professional wrestler than a Major League closer.

Diaz’s Baseball Savant profile looks like a video game cheat code. He’s leading the Majors in expected ERA, expected wOBA, expected batting average, expected slugging percentage, strikeout rate, whiff rate and ranks in the 99th percentile in average exit velocity, opponents’ chase rate, opponents’ barrel rate and fastball velocity. Diaz last allowed an earned run on June 18, and in 18 innings since that time he’s posted a 38-to-1 K/BB ratio while yielding just seven hits.

The 2022 version of Edwin Diaz might be the best reliever we’ve seen since Mariano Rivera. He’ll be hit with a qualifying offer, but it’s doubtful the teams pursuing him are going to even care about that. It’d be a surprise if Diaz doesn’t set a new contract record for relief pitchers this winter, and he could be baseball’s first nine-figure reliever.

Honorable Mentions: Brandon Nimmo, Willson Contreras, Jose Abreu, Josh Bell, Chris Bassitt, Nathan Eovaldi, Andrew Benintendi

Mets Plan To Activate Jacob deGrom On Tuesday

By Anthony Franco | July 30, 2022 at 8:02am CDT

The Mets are planning to reinstate Jacob deGrom from the 60-day injured list next Tuesday, reports Anthony DiComo of MLB.com. The two-time Cy Young winner will make his season debut against the Nationals.

deGrom hasn’t pitched in a major league game in just shy of 13 months. He was on his way to one of the most dominant pitching seasons in history last year, working to an absurd 1.08 ERA with a 45.1% strikeout rate through 15 starts. deGrom had a few injury concerns along the way, however, and he landed on the IL coming out of the All-Star Break due to a forearm/ebow issue. That eventually proved to be season-ending, with the righty’s final outing of the year coming on July 7.

New York anticipated reinstalling deGrom atop the rotation alongside offseason free agent pickup Max Scherzer to form the game’s scariest 1-2 punch. Just before Opening Day, deGrom experienced some shoulder soreness during a between-starts throwing session. He was diagnosed with a stress reaction in his scapula, an issue that cost him almost the first four months of the 2022 campaign.

deGrom has been building back to game action for a while, and he began a minor league rehab assignment at the start of July. He’s made four starts, topping out at four innings and 67 pitches. deGrom’s most recent appearance at Triple-A Syracuse came on Wednesday, so he’ll get a six-day rest before joining the big league club. DiComo writes that he’ll unsurprisingly be on a strict pitch limit for his first appearance, but the Mets anticipate he’ll gradually build towards a traditional starter’s workload throughout the second half.

The Mets rotation will be more or less at full strength for the first time all year. deGrom will step into an excellent starting five alongside Scherzer, Chris Bassitt, Taijuan Walker and Carlos Carrasco. Scherzer has been his typically dominant self, while Walker has somewhat quietly posted a 2.67 ERA across 17 starts. Bassitt had a rough stretch between May and June, though the typically reliable righty has bounced back with a 3.20 mark this month. Carrasco is a more than qualified fifth option, posting a 4.07 ERA with better than average strikeout, walk and ground-ball rates. David Peterson is a solid sixth starter. The Mets do remain without righty Tylor Megill due to a shoulder injury. Manager Buck Showalter told reporters yesterday the club was viewing Megill as a bullpen option for the rest of this season once he makes his return, which won’t be until at least late August (via Tim Britton of the Athletic).

The Mets are a virtual lock to make the postseason in some capacity, and the organization is surely anticipating running out three or four members of that group in a playoff rotation. The more immediate concern is holding onto a three-game lead over the defending champion Braves in the NL East, with the new postseason format’s first-round bye making it particularly advantageous to finish as a top-two seed in each league. It appears the National League’s byes will wind up going to the Dodgers and the East winner.

As for deGrom, he’ll have two months (plus any postseason action) to reestablish himself as the sport’s best pitcher now that he’s healthy. In spite of his absence, the 34-year-old has maintained he plans to opt out of the final guaranteed season of his deal at the end of this year. That’d be a no-brainer decision if he demonstrates he remains at peak form for the final couple months, particularly with one of the top impending free agent starters (Joe Musgrove) now unlikely to hit the market.

Jacob deGrom To Begin Minor League Rehab Assignment

By Mark Polishuk | July 2, 2022 at 4:12pm CDT

Jacob deGrom has hit another key marker in his injury recovery, as Mets GM Billy Eppler and manager Buck Showalter told reporters (including Deesha Thosar of The New York Daily News) that deGrom will begin a minor league rehab assignment on Sunday with the Mets’ low-A affiliate. DeGrom is slated to toss two innings and roughly 25 pitches.

It will mark deGrom’s first official game action of any kind in almost a full year, as the former NL Cy Young Award winner tossed seven innings against the Brewers on July 7, 2021 before forearm problems prematurely ended his 2021 season. During Spring Training, deGrom was then set back by a stress reaction in his right shoulder, again keeping the ace on the sidelines.

Given the long layoff, deGrom has been slowly brought along, and that timeline won’t change now that he has embarked on his rehab assignment. Eppler compared deGrom’s planned workload for Sunday’s game to what would be expected from a pitcher in his first Spring Training outing, and the Mets plan to be fluid with deGrom’s schedule going forward (i.e. he might not pitch every five days). Even if all goes well, this elongated timeline means that deGrom will surely still be on the injured list until after the All-Star break, and he might not be fully ready to return to the big leagues until early in August.

Still, there does appear to be some light at the end of what has surely been a frustrating tunnel for deGrom. While the Mets are still in first place in the NL East even without their longtime ace (and other key players like Max Scherzer for long portions of the season), the Braves have moved to within 3.5 games of the division lead, and the Phillies have played much better baseball over the last month. Beyond just the NL East, the Mets will surely need their rotation in top form if they hope to continue their strong play into the postseason and then contend for a World Series title.

Given how aggressive the Mets were in the offseason, starting pitching is probably on the team’s deadline checklist even if deGrom progresses well in his rehab. At full strength, New York’s first-choice rotation of deGrom, Scherzer, Carlos Carrasco, Chris Bassitt, and Taijuan Walker is among the best in the league, but health is certainly no guarantee. Eppler told Thosar and other media members that he is open to all possibilities at the deadline, and that owner Steve Cohen has no issue continuing to spend big in the right situation.

Mets Notes: McCann, Scherzer, Holderman, deGrom

By Mark Polishuk | June 25, 2022 at 10:24pm CDT

James McCann was activated from the 10-day injured list prior to today’s 5-3 win over the Marlins, and the catcher went 1-for-4 with a single and a run scored in his first game since May 10. McCann had to undergo surgery to fix a broken left hamate bone, costing him a little beyond the initial six-week recovery timeline. Nevertheless, McCann is back behind the plate and looking to finally get his Queens tenure on track. Since signing a four-year, $40.6MM free agent deal in the 2020-21 offseason, McCann has hit only .227/.290/.341 over his first 142 games and 476 plate appearances in a Mets uniform.

Neither Tomas Nido or Patrick Mazeika shone while McCann was out, so there isn’t much chance of McCann losing his starting job….unless the aggressive Mets either added a short-term catcher (i.e. a pending free agent like Willson Contreras) or perhaps promoted star prospect Francisco Alvarez. While Alvarez is crushing Double-A pitching, it would be bold to see the Mets promote him past Triple-A and directly to the majors, so the club would certainly prefer to just see McCann flash some of his good hitting form from the 2019-20 seasons.

Mets Notes: Scherzer, deGrom, Megill

By Anthony Franco | June 21, 2022 at 9:47pm CDT

The Mets co-aces each hit a milestone in their recoveries from injury today. Max Scherzer made a rehab start with Double-A Binghamton, tossing 3 1/3 innings and 65 pitches. It’s the first game action for the three-time Cy Young winner since he suffered an oblique strain in mid-May.

Jon Heyman and Mark Sanchez of the New York Post wrote over the weekend that Scherzer could return to the big league staff as soon as Sunday. Whether he’s back that quickly remains to be seen, but it’s possible he could beat the initial timeline. The club originally estimated his recovery at six-to-eight weeks; this Thursday will mark the five-week mark since the injury. Even if Scherzer does wind up requiring one more rehab start before returning to the majors, the Mets surely have to be happy with his current situation considering the initial expectations.

The team announced that Jacob deGrom threw a live batting practice session at their Florida complex (via Deesha Thosar of the New York Daily News). It’s the first time deGrom has thrown to hitters since he was diagnosed with a stress reaction in his scapula at the end of Spring Training. The four-time All-Star has been working off the mound for the past couple weeks, and he continues to progress toward an eventual return. A specific timeline for him logging game action is to be determined, and deGrom is expected to require at least three rehab starts before getting back on the Citi Field mound.

In addition to Scherzer and deGrom, New York will be without Tylor Megill for an extended period. The right-hander suffered a shoulder strain and landed on the injured list last week, with the club announcing he’d be shut down from throwing entirely for at least a month.

Megill only managed a 5.01 ERA through nine starts before the injury, but he struck out a quality 27% of batters faced against a 6.3% walk rate. He’s started all 27 of his major league appearances dating back to last year’s call-up, but the Mets have at least given some thought to using him in shorter stints. Ken Rosenthal suggested on this week’s Athletic Baseball Show that New York had some internal discussions about the possibility of converting Megill into a high-leverage setup role once Scherzer and deGrom returned to join Carlos Carrasco, Taijuan Walker, Chris Bassitt and depth starters David Peterson and Trevor Williams.

Rosenthal noted those hypotheticals were kicked around before Megill’s injury, which could throw a wrench into any plans. It seems likely he’d require less of a rehab buildup to work out of relief than as a starter, perhaps increasing the appeal of such a move though. Either way, Megill won’t be on an MLB mound for an extended period, and intervening events will no doubt affect the club’s course of action. He’s likely to be out through the August 2 trade deadline, and New York figures to explore the market for both starting and relief help over the coming weeks.

Injury Notes: deGrom, Muncy, Heaney, Flaherty, Dickerson

By Mark Polishuk | June 4, 2022 at 6:59pm CDT

Jacob deGrom hit a notable checkpoint in his injury recovery today, as the Mets ace threw a 19-pitch bullpen session. GM Billy Eppler told reporters (including MLB.com’s Anthony DiComo) that deGrom threw only fastballs of “moderate intensity,” and deGrom will continue to build up his arm strength and readiness with more bullpen sessions in the coming days.

Between the planned program of these bullpens, live batting practice, and then 3-5 rehab starts in the minors, deGrom is tentatively scheduled to make his season debut in July. This timeline is still fluid, of course, given how today’s bullpen session marked the very first time deGrom has even pitched off a mound since March. Between a forearm issue that prematurely ended his 2021 season and then a stress reaction in his right shoulder during Spring Training, deGrom hasn’t pitched in a Major League game since July 7, 2021.

More on other injury situations around baseball…

Max Muncy and Andrew Heaney began rehab assignments with the Dodgers’ Triple-A affiliate, with both veterans in tonight’s starting lineup. Muncy was only played on the 10-day IL on May 28, and given how he has been playing with a partial UCL tear since last October, it is a very promising sign to see him already on a rehab assignment, though it isn’t know how many games Muncy will play in Triple-A. Heaney seems likely to receive multiple rehab starts considering his longer stint on the injured list, as shoulder discomfort sidelined the left-handed back on April 20.
Jack Flaherty is also set to start his own rehab assignment, as the Cardinals right-hander is scheduled to pitch Sunday for Double-A Springfield. Cards manager Oliver Marmol told MLB.com’s John Denton and other reporters that Flaherty will throw 40-45 pitches, and depending on his status following that outing, will then throw either 40-45 pitches or 55-60 pitches in his next rehab start. Shoulder problems have plagued Flaherty in each of the last two seasons, and he has yet to pitch in 2022 due to inflammation in his right shoulder during Spring Training.
In other St. Louis injury news, Corey Dickerson made an early exit from the first game of the Cardinals’ doubleheader with the Cubs. Dickerson was replaced in right field prior to the bottom of the second inning due to left calf discomfort, and it isn’t clear if the injury was triggered by anything in the game, as Dickerson had yet to make a play in the field or take an at-bat. After signing a one-year, $5MM free agent deal with St. Louis in March, Dickerson has hit only .194/.245/.286 in his first 106 plate appearances, though he is coming off his best game of the season — Dickerson hit his first two home runs of 2022 in the Cardinals’ 14-5 victory over the Cubs on Friday.

Mets Notes: deGrom, Megill, McNeil

By Anthony Franco | May 25, 2022 at 7:13pm CDT

The Mets have been without Jacob deGrom all season, although the club has maintained he’s progressing well in his recovery from a Spring Training stress reaction in his scapula. deGrom has been throwing off flat ground for a couple weeks, and Deesha Thosar of the New York Daily News tweeted yesterday that he’s lengthened out to throwing from 95-100 feet.

More encouragingly, Thosar suggests the star right-hander could progress to throwing a bullpen session by this weekend. That’d mark a notable step in his recovery, although he’ll presumably need multiple mound sessions before he progresses to facing live hitters. Anthony DiComo of MLB.com wrote last week that deGrom is also expected to require three-to-five rehab starts in the minor leagues before returning to the majors.

There are still significant hurdles before deGrom will be back in a game at Citi Field, but he continues to make incremental strides. Jon Heyman of the New York Post said on yesterday’s The Show podcast with colleague Joel Sherman that he’d heard a “late June” potential timetable for deGrom’s return to the big leagues from a team source (Mets’ talk around 34:00 mark). Even if his rehab lingers a bit beyond then, the organization is surely hopeful the two-time Cy Young winner will be healthy for the second half of the season.

The Mets are also down Max Scherzer and Tylor Megill, leaving them to rely on their rotation depth. Scherzer isn’t likely to be back before the All-Star Break, while Megill has been out since May 15 because of biceps inflammation. Pitching coach Jeremy Hefner suggested Megill’s further along in his recovery than deGrom (Thosar link), but he’s not yet thrown a bullpen session and certainly won’t be ready to return when first eligible on Friday.

While the rotation has taken some key hits, the position player group has been healthy aside from catcher James McCann (out through late June because of a hand fracture). Second baseman/left fielder Jeff McNeil is now day-to-day after crashing into the wall chasing a fly ball this afternoon. Mike Puma of the Post was among those to relay (on Twitter) that he’s been diagnosed with a left knee contusion.

The subject of some trade speculation over the winter, the lefty-hitting McNeil is rewarding the organization’s decision to keep him in Flushing. Across 170 plate appearances, he’s hitting .323/.376/.458 with a minuscule 10% strikeout rate. McNeil only has two home runs, but he’s among the top 25 qualified hitters in both batting average and on-base percentage.

Mets Sign Trevor Cahill To Minor League Contract

By Anthony Franco | May 20, 2022 at 11:23am CDT

The Mets recently agreed to a minor league deal with veteran starter Trevor Cahill, as Joel Sherman of the New York Post first reported. According to the righty’s transactions tracker at MLB.com, he has been assigned to the team’s Florida complex.

Cahill will presumably head to Triple-A Syracuse at some point, but Sherman notes that he’ll first need time to build into game shape. That’s no surprise, as he hasn’t pitched since last June. A member of the Pirates at the time, Cahill landed on the injured list with a left calf strain. He was quickly transferred to the 60-day IL and didn’t return, quietly hitting free agency at the end of the year.

Before the injury, Cahill made nine appearances (including eight starts) for the Bucs. He managed just a 6.57 ERA over 37 innings, striking out a below-average 19.3% of opposing hitters. The sinkerballer induced grounders at a typically robust 55.2% clip, though, and he’s been excellent at keeping the ball in the yard throughout his career.

Cahill doesn’t throw hard or miss many bats, and his results have been inconsistent in recent years. Yet the 12-year big league veteran has continued to earn opportunities as a depth arm, having reached the majors each season since 2009. After an early run as a rotation stalwart with the A’s and Diamondbacks, Cahill has suited up for eight different clubs over the past seven seasons.

He’s a perfectly sensible veteran depth option for the Mets, who have taken some hits to their star-studded rotation. Jacob deGrom has still yet to pitch recovering from the stress reaction that arose in his throwing shoulder late in Spring Training. He is throwing but not yet ready for a minor league rehab assignment, and a specific timeline is still unclear. (Jon Heyman of the Post noted yesterday that he’s not likely to be available until some point in July). Making matters worse, New York just lost co-ace Max Scherzer for six-to-eight weeks because of an oblique strain.

Tylor Megill is also on the injured list because of biceps inflammation, although the prognosis seems more promising there. Anthony DiComo of MLB.com tweeted last night that Megill is tentatively expected to play catch today, his first time throwing since hitting the IL a week ago. If all goes according to plan, it doesn’t seem the 26-year-old is in for too long an absence.

For the moment, New York is set to rely on a primary starting five of Chris Bassitt, Carlos Carrasco, Taijuan Walker, David Peterson and Trevor Williams. That’s a solid group — particularly for a team down three of its top arms — but New York has already had to call on their depth options and the minor league ranks have thinned out. Further rotation injuries could put the organization in a precarious spot, so they’ll add Cahill as an insurance option.

« Previous Page

Load More Posts

Show all

Headlines

Jacob deGrom

Navigation

MLBTR INFO

Connect